Announcing our partnership with Artemis AI

Preview text: Announcing our partnership with Artemis AI A perpetual, exclusive licence across DDR…

Tuesday, Nov 10, 2026 at 12:27 PM EasternMailchimp

Rakovina TherapeuticsAnnouncing our partnership with Artemis AI

Fit to screenFull size

Using this email in an article? Credit: Rakovina Therapeutics email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: Announcing our partnership with Artemis AI
Preview text: Announcing our partnership with Artemis AI A perpetual, exclusive licence across DDR…
From: ir@rakovinatherapeutics.com
Brand: Rakovina Therapeutics
ESP: Mailchimp
Sent: Tue Nov 10, 2026, 12:27 PM ET
Size: 53 KB
Images: 3
Links: 11, 1 of them buttons
Subject length: 42 characters

Against Rakovina Therapeutics's usual

Sent in the 12 PM hour, which holds 6% of its emails; 31% arrive in the 4 PM hour. The subject is 42 characters; its average is 70.

	Nov 10, 2026 12:27 PM	Announcing our partnership with Artemis AI (this email)
	Nov 4, 2026 10:45 AM	Live tomorrow: the kt-5000AI story with Kim Oishi, Dr. Mads Daugaard and Handol Kim
	Oct 30, 2026 11:32 AM	AI narrows the focus for our brain-targeted cancer drug
	Oct 22, 2026 4:17 PM	kt-5000AI update: what we’ve shown, and what’s next
	Oct 18, 2026 4:14 PM	Rakovina secures exclusivity on kt-5000 target profile · Resent
	Oct 15, 2026 10:30 AM	Rakovina secures exclusivity on kt-5000 target profile
	Oct 1, 2026 4:18 PM	Rakovina partners with Celvion: what it means for our ATR program